QA: Therapeuticsmd Inc in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000025743_2012_Therapeuticsmd_Inc.pdf

Logs

info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0000025743, Therapeuticsmd Inc

  xvar xval
0 AssetsCurrent 1,237,274
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 70,113
3 remainder_Assets 131,334
4 LiabilitiesCurrent 3,150,579
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,406,197
9 ResearchAndDevelopmentExpense 107,241
10 remainder_Expenses 1,001,957
11 remainder_Revenues 2,088,177
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,438,721
1 Liabilities 3,150,579
2 Expenses 7,515,395
3 Revenues 2,088,177
4 StockholdersEquity -1,711,858
5 NetIncome -5,427,218
6 ComprehensiveNetIncome -5,427,218
7 BaseVar 7,096,436
8 EconomicCapitalRatiobeforeLimitedLiability -3.99
9 EconomicCapitalRatio 0.394

Edgar->Model Mapping

Feature Distribution